Subsequently, we tested whether reduced BCR signaling observed in SLE B cells and RA and pSS memory B cells can be induced in HD B cells by continuous stimulation with anti-BCR or TLR9 antagonists (Figure 3). The gene discussed is TLR9; the disease is systemic lupus erythematosus.